Mississauga, Canada
Contract Pharmaceuticals Limited Canada recalls
2 recalls recorded since 2018, most recently on 20 February 2024. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)1
Terminated or completed1
Class I (FDA)0
Ongoing Class III Drugs
- Recall started
- 20 February 2024
- Reason
- Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
- Distribution
- Nationwide in the U.S. and Puerto Rico
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0364-2024, D-0365-2024
- Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61
- Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60
Terminated Class III Drugs
- Recall started
- 23 August 2023
- Terminated
- 6 August 2025
- Reason
- Defective Container: slow leakage under the cap
- Distribution
- Nationwide in the USA.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1139-2023
- Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada,
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.